Alejandro Zuretti, MD

Alejandro Zuretti, MD

Clinical Chemistry
Department of Pathology

Education and Training
  • 1971-1976   National College of Buenos Aires, Buenos Aires, Argentina, Bachelor's Degree, Magna cum laude
  • 1977-1983   School of Medicine, University of Buenos Aires, Argentina Doctor of Medicine, Cum Laude
  • 1985-1986   Internship in Internal Medicine, St. John’s Episcopal Hospital. New York
  • 1986-1990   Residency in Anatomic and Clinical Pathology, The Mount Sinai Medical Center, New York, NY
  • 1990-1991   Fellowship in Surgical Pathology, The Mount Sinai Medical Center, New York, NY
Professional Associations
  • College of American Pathologists, Fellow and Inspector, Team Leader
  • The Joint Commission, Pathologist Specialist and Laboratory Inspector
  • American Society for Clinical Pathology, Fellow
  • American Association for Clinical Chemistry, Member
  • Human Research and Biomedical Investigator – Collaborative Institutional Training Initiative   
Certifications and Licenses
  • Board Certification by the American Board of Pathology in Anatomic and Clinical Pathology, 1991
  • New York State Medical License, 1992
  • New York State Laboratory Director Certificate of Qualification including Bacteriology, Blood Banking Collection-Comprehensive, Blood Lead, Blood pH and Gases, Clinical Chemistry, Clinical Toxicology, Cytopathology, Diagnostic Immunology, Endocrinology, Hematology, Histopathology General, Immunohematology, Mycology, Oncology Soluble Tumor Markers, Parasitology, Therapeutic Substance Monitoring/Quantitative Toxicology, Transfusion Services and Virology
Research and Clinical Interest Summary

My areas of interest are varied, focusing on those that have direct clinical impact on treatments.  Currently I am involved in assessing cost-effective semi-quantitative diagnostic methods to determine antibody titers in convalescent COVID-19 plasma samples, correlations between cytokine levels and inflammatory presentation in pediatric COVID-19 patients,  a Time-Series analysis of laboratory values in the context of hospitalized COVID-19 Patients, and a grant funded project on  reduction of prostate biopsy morbidity and hospitalization through a modified biopsy protocol bundle and region-specific antibiogram.

  • Abstract:  Anti-covid antibody generation after vaccination and natural infection over time.  Christian M, Allen J, Bluth MJ, Zuretti A, Bluth MH.  AACC 2022.
  • Abstract:  Christian M, Allen J, Bluth MJ, Zuretti A, Bluth MH. Anti-COVID antibody generation after vaccination: Presence of IgM vs IgG over time. Poster presentation at the American Association of Blood Banks Annual meeting (virtual), October 17-19, 2021. 
  • Mendoza, R., Momeni, A., Stopard, I., Lambert, B., Zuretti A. : A Dynamic Bayesian Model for Identifying High-Mortality Risk in Hospitalized COVID-19 Patients, Infectious Disease Reports 2021, 13(1), 239-250; , 2021 
  • Mendoza, R., Silver, M., Zuretti A.., Christian, M., Das, B., Norin, A.J., Borgen, P., Libien J., Bluth, M.H.: Correlation of Automated Chemiluminescent Method with Enzyme-Linked Immunosorbent Assay (ELISA) Antibody Titers in Convalescent COVID-19 Plasma Samples: Development of Rapid, Cost-Effective Semi-Quantitative Diagnostic Methods, Journal of Blood Medicine Vol 2021:12 Pages 157—164 doi: , 2021
  • Momeni, A., Yousefi, E. and Zuretti, A.:  Time series analysis of laboratory values in the context of long-term hospitalized patient mortality. American Journal of Clinical Pathology,  doi/10.1093/ajcp/aqy163/5303265 , 2019
  • Chua, C., Tifigiu, E., Momeni, A., Laskar, D., Shafique, K., Zuretti, A., Michl, J., and  Pincus, M.: Stability of Values for the Activities of Critical Enzymes Assayed in Serum Frozen for Prolonged Time Periods.  Annals of Clinical & Laboratory Science, 48:618-626  doi: 10.15761/CDP.1000115 ,2018
  • Laskar, D., Shafique, K., Lu, C. and Zuretti, A.:  Evaluation and characterization of monoclonal gammopathies using serum protein electrophoresis in a major urban population: one institution’s experience.  Journal of Investigative Medicine,  doi: 10.1136/jim-2017-000446  , 2017
  • Chua, C., Tifigiu, E., Momeni, A., Laskar, D., Shafique, K., Zuretti, A., Michl, J., and Pincus, M.: Stability of values for the activities of critical enzymes assayed in serum.
  • Leonardi, G.,Wilson, A. and Zuretti, A.:.  Evaluation of respiratory syncytial virus (RSV) direct antigen detection assays for use in point-of-care testing.  Journal of Virological Methods, 213, 131-134, 2015
  • Leonardi, G.,Wilson, A. and Zuretti, A.: Comparison of Conventional Lateral-flow Assays and a New Fluorescent Immunoassay    to Detect Influenza VirusesJournal of Virological Methods 189, 379-382   Ref: VIRNET12078, 2013
  • Gao, L., Lipka, A., Avezbakiyev, B., Zuretti, A and Mustacchia, P.:  Synchronous Duodenal Carcinoid and Adenocarcinoma of the Colon.   World Journal of Oncology; 3(5):239-242, 2012
  • Barnett, W and Zuretti, A.:  Recurrent Malignant Chondroid SyringomaAmerican Journal of Clinical Oncology, Vol 23, No 3, 227-232, 2000
  • L. Mesia, and Zuretti, A.:  Ossified Intratesticular Mucinous TumorArchives of Pathology and Laboratory Medicine; Vol 123, 244-246, 1999
  • Cacciarelli, A., Zuretti, A. and Robilotti, J.:  Lower Helicobacter Pylori Infection and Peptic Ulcer Disease Prevalence in Patients with AIDS and Suppressed CD4 Counts.   American Journal of Gastroenterology; 91, No 9, 1783-1784, 1996
  • Cacciarelli,A., Abdel Dayem, H.M  and Zuretti, A.:  Acute Cholecystitis in AIDS Patients: Correlation of Tc 99M Hepatobiliary Scintigraphy with Histopathological Laboratory Findings and CD counts.  The society of Nuclear Medicine, November 1995
  • Zuretti, A and Schwartz, I.: Gangrenous Herpetic Whitlow, American Journal of Clinical Pathology; 93:828-830, 1990

Department Links